Pulmonary function testing

93
Pulmonary Function Testing The Basics of Interpretation

Transcript of Pulmonary function testing

Page 1: Pulmonary function testing

Pulmonary Function Testing

The Basics of Interpretation

Page 2: Pulmonary function testing

Anatomy

• Lungs comprised of – Airways– Alveoli

http://www.aduk.org.uk/gfx/lungs.jpg

Page 3: Pulmonary function testing

Weibel ER: Morphometry of the Human Lung. Berlin and New York: Springer-Verlag, 1963

The Airways

• Conducting zone: no gas exchange occurs

– Anatomic dead space

• Transitional zone: alveoli appear, but are not great in number

• Respiratory zone: contain the alveolar sacs

Page 4: Pulmonary function testing

The Alveoli

• Approximately 300 million alveoli

• 1/3 mm diameter• Total surface area if

they were complete spheres 85 sq. meters (size of a tennis court)

Murray & Nadel: Textbook of Respiratory Medicine, 3rd ed., Copyright © 2000 W. B. Saunders Company

Page 5: Pulmonary function testing

Pulmonary function test :Group of procedures that measure the function of the

lungs

1. Spirometry

2. Lung volumes

3. Gas transfer

4. Bronchial chalenge

Page 6: Pulmonary function testing

Spirometry

• Measurement of the pattern of air movement into and out of the lungs during controlled ventilatory maneuvers.

• Often done as a maximal expiratory maneuver

Page 7: Pulmonary function testing

Spirometry

Measures flow, volumes

Volume vs. Time

Can determine:- Forced expiratory volume in one second (FEV1)

- Forced vital capacity (FVC)

- FEV1/FVC

- Forced expiratory flow 25%-75% (FEF25-75)

Page 8: Pulmonary function testing

What is a spirometry ??Spirometry is a measure of airflow and

lung volumes during a forced expiratory

maneuver from full inspiration

Page 9: Pulmonary function testing

1. Volume Time Graph 2. Flow-volume loops

Page 10: Pulmonary function testing

Lung Volumes

Page 11: Pulmonary function testing

Terminology

• Forced vital capacity (FVC):– Total volume of air that can

be exhaled forcefully from TLC

– The majority of FVC can be exhaled in <3 seconds in normal people, but often is much more prolonged in obstructive diseases

– Measured in liters (L)

Page 12: Pulmonary function testing

FVC

• Interpretation of % predicted:– 80-120% Normal

– 70-79% Mild reduction

– 50%-69% Moderate reduction

– <50% Severe reduction

FVC

Page 13: Pulmonary function testing

Terminology

• Forced expiratory volume in 1 second: (FEV1)– Volume of air forcefully

expired from full inflation (TLC) in the first second

– Measured in liters (L)– Normal people can exhale

more than 75-80% of their FVC in the first second; thus the FEV1/FVC can be utilized to characterize lung disease

Page 14: Pulmonary function testing

FEV1

• Interpretation of % predicted:– >75% Normal

– 60%-75% Mild obstruction

– 50-59% Moderate obstruction

– <49% Severe obstruction

FEV1 FVC

Page 15: Pulmonary function testing

Terminology

• Forced expiratory flow 25-75% (FEF25-75)– Mean forced expiratory flow

during middle half of FVC – Measured in L/sec– May reflect effort

independent expiration and the status of the small airways

– Highly variable– Depends heavily on FVC

Page 16: Pulmonary function testing

Spirometry

Page 17: Pulmonary function testing

Volume Time Graph The volume is plotted against the time, it displays

the expiration.

Page 18: Pulmonary function testing

1. FVC

2. FEV1

3. FEV1/FVC

4. FEF25%

5. FEF75%

Page 19: Pulmonary function testing

Forced Vital Capacity (FVC)

The total amount of air expired as quickly as possible after taking the deepest possible breath.

Page 20: Pulmonary function testing

FEV1 :

Volume of air which can be forcibly exhaled from the lungs in the first second of a forced expiratory maneuver.

Page 21: Pulmonary function testing

FEV1/FVC

Ratio of FEV1 to FVC :

It indicates what percentage of the total FVC was expelled from the lungs during the first second of forced exhalation

This value is critically important in the diagnosis of obstructive and restrictive diseases

Page 22: Pulmonary function testing

FEF25%

Amount of air that was forcibly expelled in the first

25% of the total forced vital capacity test.

FEF75%

The amount of air expelled from the lungs during the

first (75%) of the forced vital capacity test.

FEF25%-75%

The amount of air expelled from the lungs during the

middle half of the forced vital capacity test.

Page 23: Pulmonary function testing

Normal Spirometry

Page 24: Pulmonary function testing

Obstructive Pattern

■ Decreased FEV1

■ Decreased FVC

■ Decreased FEV1/FVC

- <70% predicted

■ FEV1 used to follow severity in COPD

Page 25: Pulmonary function testing

Obstructive Lung Disease — Differential Diagnosis

Asthma

COPD - chronic bronchitis

- emphysema

Bronchiectasis

Bronchiolitis

Upper airway obstruction

Page 26: Pulmonary function testing

Restrictive Pattern

Decreased FEV1

Decreased FVC

FEV1/FVC normal or increased

Page 27: Pulmonary function testing

Restrictive Lung Disease —Differential Diagnosis

Pleural

Parenchymal

Chest wall

Neuromuscular

Page 28: Pulmonary function testing

Spirometry Patterns

Page 29: Pulmonary function testing

Bronchodilator Response

Degree to which FEV1 improves with inhaled bronchodilator

Documents reversible airflow obstruction

Significant response if:

- FEV1 increases by 12% and >200ml

Request if obstructive pattern on spirometry

Page 30: Pulmonary function testing

Flow-volume loops

Page 31: Pulmonary function testing

Flow Volume Loop

“Spirogram”

Measures forced inspiratory and expiratory flow rate

Augments spirometry results

Indications: evaluation of upper airway obstruction (stridor, unexplained dyspnea)

Page 32: Pulmonary function testing

Flow-Volume Loop

• Illustrates maximum expiratory and inspiratory flow-volume curves

• Useful to help characterize disease states (e.g. obstructive vs. restrictive)

Ruppel GL. Manual of Pulmonary Function Testing, 8th ed., Mosby 2003

Page 33: Pulmonary function testing

Flow Volume Loop

Page 34: Pulmonary function testing

Obstructive Disorders

• Characterized by a limitation of expiratory airflow– Examples: asthma,

COPD

• Decreased: FEV1, FEF25-75, FEV1/FVC ratio (<0.8)

• Increased or Normal: TLC

Page 35: Pulmonary function testing

Restrictive Lung Disease

• Characterized by diminished lung volume due to:– change in alteration in lung

parenchyma (interstitial lung disease)

– disease of pleura, chest wall (e.g. scoliosis), or neuromuscular apparatus (e.g. muscular dystrophy)

• Decreased TLC, FVC

• Normal or increased: FEV1/FVC ratio

Page 36: Pulmonary function testing

Upper Airway Obstruction

Variable intrathoracic obstruction

Variable extrathoracic obstruction

Fixed obstruction

Page 37: Pulmonary function testing

Fixed obstruction1. Post intubation stenosis

2. Goiter

3. Endotracheal neoplasms

4. Bronchial stenosis

Maximum airflow is limited to a similar extent in both inspiration and expiration

Page 38: Pulmonary function testing

Variable extrathoracic

Obstruction1. Bilateral and unilateral vocal cord

paralysis

2. Vocal cord constriction

3. Reduced pharyngeal cross-sectional area

4. Airway burns

The obstruction worsens in inspiration because the negative pressure narrows the trachea and inspiratory flow is reduced to a greater extent than expiratory flow

Page 39: Pulmonary function testing

In variable intrathoracic

obstruction

1. Tracheomalacia

2. Polychondritis

3. Tumors of the lower trachea or main bronchus.

The narrowing is maximal in expiration because of increased intrathoracic pressure compressing the airway.

The flow volume loop shows a

greater reduction in the expiratory phase

Page 40: Pulmonary function testing

Upper Airway Obstruction

Page 41: Pulmonary function testing

Lung Volumes

Measurement:- helium- nitrogen washout- body plethsmography

Indications: - Diagnose restrictive component

- Differentiate chronic bronchitis from emphysema

Page 42: Pulmonary function testing

Lung Volumes – Patterns

Obstructive

- TLC > 120% predicted

- RV > 120% predicted

Restrictive

- TLC < 80% predicted

- RV < 80% predicted

Page 43: Pulmonary function testing

Diffusing Capacity

Diffusing capacity of lungs for CO

Measures ability of lungs to transport inhaled gas from alveoli to pulmonary capillaries

Depends on:

- alveolar—capillary membrane

- hemoglobin concentration

- cardiac output

Page 44: Pulmonary function testing

Diffusing Capacity

Decreased DLCO (<80% predicted)

Obstructive lung disease

Parenchymal disease

Pulmonary vascular disease

Anemia

Increased DLCO (>120-140% predicted)

Asthma (or normal)

Pulmonary hemorrhage

Polycythemia

Left to right shunt

Page 45: Pulmonary function testing

DLCO — Indications

Differentiate asthma from emphysema

Evaluation and severity of restrictive lung disease

Early stages of pulmonary hypertension

Page 46: Pulmonary function testing

Case 1

CC/HPI: A 36yo WM, nonsmoker, presents to your clinic with c/o episodic cough for 6mo. Also reports occasional wheezing and dyspnea with exertion during softball practice.

Exam: Heart RRR, no murmurs; Lungs CTAB, no labored breathing

Based on your exam and a thorough review of systems, you suspect asthma and decide to order spirometry for further evaluation.

Page 47: Pulmonary function testing

Continued…

PFTs: FEV1 86% predicted

FEV1/FVC 82% predicted

Flow Volume Loop: normal inspiratory and expiratory pattern

You still suspect asthma. What is your next step in the workup of this patient?

Page 48: Pulmonary function testing

Bronchoprovocation

Useful for diagnosis of asthma in the setting of normal pulmonary function tests

Common agents:

- Methacholine, Histamine, others

Diagnostic if: ≥20% decrease in FEV1

Page 49: Pulmonary function testing

Continued…

↓SYMPTOMS

PFTs

OBSTRUCTION?

YES NO

TREATBRONCHOPROVOCATION

Obstruction?

TREAT

No Obstruction?

Other Diagnosis

↓ ↓

↓ ↓

Page 50: Pulmonary function testing

Obstructive Pattern — Evaluation

Spirometry FEV1, FVC: decreased

FEV1/FVC: decreased (<70% predicted)

FV Loop “scooped”

Lung Volumes TLC, RV: increased

Bronchodilator responsiveness

Page 51: Pulmonary function testing

Restrictive Pattern – Evaluation

Spirometry FVC, FEV1: decreased

FEV1/FVC: normal or increased

FV Loop “witch’s hat”

DLCO decreased

Lung Volumes TLC, RV: decreased

Page 52: Pulmonary function testing

PFT Patterns

Emphysema

FEV1/FVC <70%

“Scooped” FV curve

TLC increased

Increased compliance

DLCO decreased

Chronic Bronchitis

FEV1/FVC <70%

“Scooped” FV curve

TLC normal

Normal compliance

DLCO usually normal

Page 53: Pulmonary function testing

PFT Patterns

Asthma

FEV1/FVC normal or decreased

DLCO normal or increased

But PFTs may be normal bronchoprovocation

Page 54: Pulmonary function testing

Pulmonary Function Testing

Which of the following is used to follow disease severity in COPD patients?

a. Total lung capacity (TLC)

b. Degree of responsiveness to bronchodilators

c. Forced vital capacity (FVC)

d. Forced expiratory volume in 1 second

e. Diffusing capacity (DLCO)

Page 55: Pulmonary function testing

Pulmonary Function Testing

Which of the following is used to follow disease severity in COPD patients?

a. Total lung capacity (TLC)

b. Degree of responsiveness to bronchodilators

c. Forced vital capacity (FVC)

d. Forced expiratory volume in 1 second

e. Diffusing capacity (DLCO)

Page 56: Pulmonary function testing

Pulmonary Function Testing

A 36yo WF, non-smoker, presents to your office for follow-up of ‘recurrent bronchitis.’ You suspect asthma and decide to order spirometry. Which of the following would you include in your prescription for testing?

a. Diffusing Capacity (DLCO)b. If no obstruction present, add trial of bronchodilatorc. If no obstruction present, perform methacholine challenged. Flow volume loope. b and c

Page 57: Pulmonary function testing

Pulmonary Function Testing

A 36yo WF, non-smoker, presents to your office for follow-up of ‘recurrent bronchitis.’ You suspect asthma and decide to order spirometry. Which of the following would you include in your prescription for testing?

a. Diffusing Capacity (DLCO)b. If no obstruction present, add trial of bronchodilatorc. If no obstruction present, perform methacholine challenged. Flow volume loope. b and c

Page 58: Pulmonary function testing

Pulmonary Function Testing

A 68yo HM is admitted to the ICU with acute respiratory distress. A CXR obtained in the ED demonstrates bilateral pulmonary infiltrates, and his DLCO is elevated. What is the most likely diagnosis?

a. Pulmonary edemab. Aspiration pneumonitisc. Pulmonary embolid. Alveolar hemorrhagee. Interstitial lung disease

Page 59: Pulmonary function testing

Pulmonary Function Testing

A 68yo HM is admitted to the ICU with acute respiratory distress. A CXR obtained in the ED demonstrates bilateral pulmonary infiltrates, and his DLCO is elevated. What is the most likely diagnosis?

a. Pulmonary edemab. Aspiration pneumonitisc. Pulmonary embolid. Alveolar hemorrhagee. Interstitial lung disease

Page 60: Pulmonary function testing

Contraindications

Page 61: Pulmonary function testing

Hemoptysis of unknown origin Pneumothorax Unstable angina pectoris Recent myocardial infarction Thoracic aneurysms Abdominal aneurysms Cerebral aneurysms Recent eye surgery (increased intraocular pressure

during forced expiration) Recent abdominal or thoracic surgical procedures History of syncope associated with forced exhalation

Page 62: Pulmonary function testing

Obstructive V/S restrictive lung disease ???

Page 63: Pulmonary function testing

Obstructive Lung Diseases

Page 64: Pulmonary function testing

Common Obstructive Lung Diseases

• Asthma

• COPD (chronic bronchitis, emphysema and the overlap between them).

• Cystic fibrosis.

Page 65: Pulmonary function testing

-Airflow is reduced because the airways narrow and the FEV1 is reduced -Spirogram may continue to rise for more than 6 seconds because lung take longer to empty -FVC may also be reduced because gas is trapped behind obstructed bronchi due to increase in intrathoracic pressure during maneuver compresses airways causing early airway closure and gas trapping but this reduction to a lesser extent than FEV1

Page 66: Pulmonary function testing

FEV1 ≥ 80% of predicted Normal

FEV1 60-80% of predicted mild obst.

FEV1 40-60% of predicted moderate

FEV1 ≤ 40% of predicted severe

The cardinal feature is FEV1/FVC ratio If

the ratio less than 70 consider obstructed

disease .*Predictors: Sex, Age, Ht

Page 67: Pulmonary function testing

Flow volume loop in

Obstructive lung disease

Page 68: Pulmonary function testing

Asthma Peak expiratory flow reduced

so maximum height of the loop is reduced

Airflow reduces rapidly with the reduction in the lung volumes because the airways narrow and the loop become concave

Concavity may be the indicator of airflow obstruction and may present before the change in FEV1 or FEV1/FVC

Page 69: Pulmonary function testing

Emphysema

Airways may collapse during forced expiration because of destruction of the supporting lung tissue causing very reduced flow at low lung volume and a characteristic (dog-leg) appearance to the flow volume curve

Page 70: Pulmonary function testing

Reversibility • Improvement in FEV1 by 12-15%

or 200 ml in repeating spirometry after treatment with Sulbutamol 2.5mg or ipratrobium promide by nebuliser after 15-30 minutes

• Reversibility is a characterestic feature of B.Asthma

• In chronic asthma there may be only partial reversibility of the airflow obstruction

• While in COPD the airflow is irriversible although some cases showed significant improvement.

Page 71: Pulmonary function testing

Interpretation of PFTs

Step 1. Look at the Flow-Volume loop to determine acceptability of the test, and look for upper airway obstruction pattern.

Step 2. Look at the FEV1 to determine if it is normal (≥ 80% predicted).

Step 3. Look at FVC to determine if it is within normal limits (≥ 80%).

Step 4. Look at the FEV1/FVC ratio to determine if it is within normal limits (≥ 70%).

Page 72: Pulmonary function testing

Step 5. Look at FEF25-75% (Normal (≥ 60%)

• If FEV1, FEV1/FVC ratio, and FEF25-75% all are normal, the patient has a normal PFT.

• If both FEV1 and FEV1/FVC are normal, but FEF25-75% is ≤ 60% ,then think about early obstruction or small airways obstruction.

Page 73: Pulmonary function testing

• If FEV1 ≤ 80% and FEV1/FVC ≤ 70%, there is obstructive defect, if FVC is normal, it is pure obstruction. If FVC ≤ 80% , possibility of additional restriction is there.

• If FEV1 ≤ 80% , FVC ≤ 80% and FEV1/FVC ≥ 70% , there is restrictive defect, get lung volumes to confirm.

Page 74: Pulmonary function testing

Small Airways obstruction

• Diseases affecting primarily the small (peripheral) airways can be extensive yet not affect the FEV1(e.g. early COPD, interstitial granulomatous disorders).

• Small airways status is reflected by the FEF25-75% (mid-range flow), best determined from the flow-volume loop.

• Some patients have normal spirometry with the exception of a reduced FEF25-75%, this is suggestive of possible small airways dysfunction and potentially early obstruction.

Page 75: Pulmonary function testing

Effect of Smoking:• Smoking in patients with COPD is associated

with decline in FEV1 of 90-150 mL/year

• Smoking cessation is (associated with

increase in FEV1 for first year) followed with a decline of only 30 mL/year

Page 76: Pulmonary function testing
Page 77: Pulmonary function testing
Page 78: Pulmonary function testing

Restrictive Lung Diseases

Page 79: Pulmonary function testing

A. Intrinsic Restrictive Lung Disorders

1. Sarcoidosis

2. Idiopathic pulmonary fibrosis

3. Interstitial pneumonitis

4. Tuberculosis

5. Pnuemonectomy (loss of lung)

6. Pneumonia

Page 80: Pulmonary function testing

B. Extrinsic Restrictive Lung Disorders

1. Scoliosis, Kyphosis

2. Ankylosing Spondylitis

3. Pleural Effusion

4. Pregnancy

5. Gross Obesity

6. Tumors

7. Ascites

8. Pain on inspiration - pleurisy, rib fractures

Page 81: Pulmonary function testing

C. Neuromuscular Restrictive Lung Disorders

1. Generalized Weakness – malnutrition

2. Paralysis of the diaphragm

3. Myasthenia Gravis

4. Muscular Dystrophy

5. Poliomyelitis

6. Amyotrophic Lateral Sclerosis

Page 82: Pulmonary function testing

• Full expantion of the lung is limited and therefore the FVC is reduced

• FEV1 may be reduced because the stiffness of fibrotic lungs increases the expiratory pressure

• FEV1/FVC will be Normal or Increased

*if you suspect restrictive pattern you must check TLC

Page 83: Pulmonary function testing

Flow volume loop in

Restrictive lung disease

Page 84: Pulmonary function testing

Flow volume loop in Restrictive lung disease :

Full lung expantion is prevented by fibrotic tissue in the lung parenchyma and the FVC is reduced .

Elastic recoil may increased by fibrotic tissue lead to increase the airflow

Both FEV1 and FVC may be reduced because the lungs are small and stiff ,but the peak expiratory flow may be preserved or even higher than predicted leads to tall,narrow and steep flow volume loop in expiratory phase.

Page 85: Pulmonary function testing
Page 86: Pulmonary function testing

Obstructive & restrictive defects

Parameter Obstruction Restriction

FEV1 Reduced Reduced

FVC Normal Reduced

FEV1/FVC Reduced Normal

Page 87: Pulmonary function testing

 

A breathless 23-year-old woman has the following lung function tests: FEV1 1.1L (60%)/ FVC 1.3 L (55%)/ FEV1/FVC ratio = 84%/ TLC = 66% predicted/ RV = 57% predicted/ TLCO = 55% predicted/ KCO = 110% predicted What is the most likely diagnosis?

A : Acute sickle crisis

B : systemic lupus erythematosus (SLE) pneumonitis

C : Scoliosis

D : Asthma

E : Cystic fibrosis.

 

 

 

 

Page 88: Pulmonary function testing

C : Scoliosis

The lung function tests show a significant restrictive defect. Only kyphoscoliosis or a pneumonitis may fit this picture but given the normal/high KCO (i.e. after correcting for alveolar volumes), the most likely answer is kyphoscoliosis as the gas exchange after correcting for the alveolar volume would in fact be high. 

Page 89: Pulmonary function testing

A 35 year old lady with systemic sclerosis has breathlesness on exertion. She has bilateral basal crepitations in the chests and corresponding interstitial shadowing on the CXR. Which is likely to be found on her lung function tests?  

A. P02 of 11 desaturating to 10 on exertion

B. FEV1 to FVC ratio of 65%

C. Diffusion capacity (DLCO) of 17 (predicted 23)

D. Increased residual volume

E. FEV1 of 5 L

Page 90: Pulmonary function testing

c) diffusion capacity (DLCO) of 17 (predicted 23). A decrease in diffusion capacity (DLCO) indicates interstitial lung disease, which is likely in a patient with basal crepitations and a predisposing connective tissue disease

Page 91: Pulmonary function testing

A 30 year old man has kyphoscoliosis affecting his respiratory function. Which one of the following is associated?

A. Inclusion body myositis

B. Genital ulceration  

C. Klebsiella pneumonia

D. Pectus excavatum

E. Osteogenesis imperfecta

 

Page 92: Pulmonary function testing

Answer: e) osteogenesis imperfecta.

Kyphoscoliosis occurs in :Connective tissue disorders -osteogenesis imperfecta, neurofibromatosis, MarfansNeuromuscular disorders – poliomyelitis, Duchenne’s , Friedrich’s ataxia, syringomyeliaPulmonary disorders – Unilateral fibrosis, empyema, pneumonectomy.

A restrictive defect occurs due to a reduction in FVC. Hypoxia is the first consequence, later hypercapnia and cor pulmonale may occur. Pectus excavatum is an inward chest wall deformity which may be due to the pull of diaphragmatic fibres during development. It is seldom symptomatic as is pectus carinatum, which is a protrusion deformity due to skeletal overgrowth.

Page 93: Pulmonary function testing